|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ELECTRONIC PAGES |
| Coronary artery disease |
1 Kuopio Research Institute of Exercise Medicine, Kuopio, Finland
2 Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland
3 Institute of Biomedicine, Physiology, University of Kuopio, Kuopio, Finland
4 School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland
5 Inner Savo Health Centre, Suonenjoki, Finland
6 Oy Jurilab Ltd, Kuopio, Finland
Correspondence to:
Dr K P Savonen, Kuopio Research Institute of Exercise Medicine, Haapaniementie 16, 70100 KUOPIO, Finland; savonen{at}hytti.uku.fi
Objective: To investigate whether a workload which an individual is able to perform at the heart rate (HR) of 100 beats/min (WL100) independently predicts mortality in middle-aged men with known or suspected coronary heart disease (CHD).
Design: Prospective population-based study based on 365 middle-aged men with known or suspected CHD at baseline.
Results: During an average follow-up of 11.1 years, there were 75 deaths (20.5%). In Cox multivariable models mortality increased by 72% (95% CI 32% to 122%, p<0.001) with 1 SD (34 Watts) decrement in WL100 after adjustment for age, examination year, alcohol consumption, body mass index, cigarette smoking, cardiac insufficiency, history of myocardial infarction, diabetes, myocardial ischaemia during exercise test, serum low-density lipoprotein and high-density lipoprotein cholesterol, systolic and diastolic blood pressure at rest, testing protocol, and use of HR-lowering medication. The risk of death was 2.4 (95% CI 1.5 to 4.0, p<0.001) times higher in 130 men with WL100 <55 W than in 235 men with WL100
55 W. In men using and not using HR-lowering medication the risk of death increased 72% (95% CI 14% to 163%, p = 0.01), and 54% (95% CI 14% to 108%, p = 0.005) with 1 SD decrement in WL100, respectively. WL100 improved the predictive power of the adjusted Cox models including other HR and exercise test variables.
Conclusions: WL100 predicts mortality in men with known or suspected CHD. The association of WL100 with mortality was not explained by other well-established HR and exercise test variables. WL100 is derived from a submaximal test which avoids the cardiovascular risks associated with a high-intensity exertion.
This article has been cited by other articles:
![]() |
K. P. Savonen, V. Kiviniemi, J. A. Laukkanen, T. A. Lakka, T. H. Rauramaa, J. T. Salonen, and R. Rauramaa Chronotropic incompetence and mortality in middle-aged men with known or suspected coronary heart disease Eur. Heart J., August 1, 2008; 29(15): 1896 - 1902. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |